CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Humoral and Cellular Capsid-Specific Immune Responses to Adeno-Associated Virus Type 1 in Randomized Healthy Donors

Abstract

A major impediment to the use of adeno-associated virus (AAV)-mediated gene delivery to muscle in clinical applications is the pre-existing immune responses against the vector. Pre-existing humoral response to different AAV serotypes is now well documented. In contrast, cellular responses to AAV capsid have not been analyzed in a systematic manner, despite the risk of T cell reactivation upon gene transfer. AAV1 has been widely used in humans to target muscle. In this study, we analyzed PBMCs and sera of healthy donors for the presence of AAV1 capsid-specific T cell responses and AAV1 neutralizing factors. Approximately 30% of donors presented AAV1 capsid-specific T cells, mainly effector memory CD8+ cells. IFN-γ–producing cells were also observed among effector memory CD4+ cells for two of these donors. Moreover, to our knowledge, this study shows for the first time on a large cohort that there was no correlation between AAV1-specific T cell and humoral responses. Indeed, most donors presenting specific Ig and neutralizing factors were negative for cellular response (and vice versa). These new data raise the question of prescreening patients not only for the humoral response, but also for the cellular response. Clearly, a better understanding of the natural immunology of AAV serotypes will allow us to improve AAV gene therapy and make it an efficient treatment for genetic disease.

Overview

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1200620

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 2

  1. Nierman, 2007, Safety and efficacy of AMT-010, an adeno-associated virus based gene therapy vector administered to lipoprotein lipase-deficient subjects, Hum. Gene Ther., 18, 942
  2. Mingozzi, 2007, Capsid-specific T cell responses in humans upon intramuscular administration of an AAV-1 vector expressing LPLs447X transgene, Hum. Gene Ther., 18, 94

Cited by

See all 88

Metadata

Authors
Veron, P., Leborgne, C., Monteilhet, V., Boutin, S., Martin, S., Moullier, P., & Masurier, C.
Affiliations
  • Genethon (France) (FR)
  • Inserm (FR)
Corresponding author
  • Veron, Philippe
  • Leborgne, Christian
  • Monteilhet, Virginie
  • Boutin, Sylvie
  • Moullier, Philippe
  • Masurier, Carole
Venue
The Journal of Immunology
Published
2012-06
Volume
188
Issue
12
Pages
6418-6424
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2170549121
Cited by
88
References
30
Citations by year
2026: 3 · 2025: 6 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 10 · 2017: 9 · 2016: 4 · 2015: 8 · 2014: 3 · 2013: 9 · 2012: 1
FWCI
4.03
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
adeno-associated virus type 1, humoral immune response, neutralizing antibodies, CD8+ effector memory T cells, CD4+ T cells, interferon-gamma, AAV serotypes, gene therapy safety, healthy donors
MeSH terms
Dependovirus, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Genetic Vectors, Humans, Immunity, Cellular, Immunologic Memory, Random Allocation, T-Lymphocytes, Genetic Therapy, Capsid Proteins, Immunity, Humoral

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Humoral and Cellular Capsid-Specific Immune Responses to Adeno-Associated Virus Type 1 in Randomized Healthy Donors. https://app.cochat.ai/papers/10.4049/jimmunol.1200620
The paper
Veron, P., Leborgne, C., Monteilhet, V., Boutin, S., Martin, S., Moullier, P., & Masurier, C. (2012). Humoral and Cellular Capsid-Specific Immune Responses to Adeno-Associated Virus Type 1 in Randomized Healthy Donors. The Journal of Immunology. https://doi.org/10.4049/jimmunol.1200620

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.